Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial
| Title: | Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial |
|---|---|
| Authors: | Goldschmidt, H; Lokhorst, HM; Mai, EK; van der Holt, Ronnie; Blau, IW; Zweegman, S; Weisel, KC; Vellenga, E; Pfreundschuh, M; Kersten, MJ; Scheid, C; Croockewit, S; Raymakers, R; Hose, D; Potamianou, A; Jauch, A; Hillengass, J; Stevens-Kroef, M; Raab, MS; Broijl, A.; Lindemann, HW; Bos, GMJ; Brossart, P; Kooy, MV; Ypma, P; Duehrsen, U; Schaafsma, RM; Bertsch, U; Hielscher, T; Jarari, L (Laila); Salwender, HJ; Sonneveld, Pieter |
| Source: | Goldschmidt, H, Lokhorst, HM, Mai, EK, van der Holt, R, Blau, IW, Zweegman, S, Weisel, KC, Vellenga, E, Pfreundschuh, M, Kersten, MJ, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, MS, Broijl, A, Lindemann, HW, Bos, GMJ, Brossart, P, Kooy, MV, Ypma, P, Duehrsen, U, Schaafsma, RM, Bertsch, U, Hielscher, T, Jarari, L, Salwender, HJ & Sonneveld, P 2018, 'Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial', Leukemia, vol. 32, no. 2, pp. 383-390. https://doi.org/10.1038/leu.2017.211 |
| Publication Year: | 2018 |
| Subject Terms: | /dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01 |
| Document Type: | article in journal/newspaper |
| Language: | unknown |
| ISSN: | 0887-6924; 1476-5551 |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/28761118; info:eu-repo/semantics/altIdentifier/pissn/0887-6924; info:eu-repo/semantics/altIdentifier/eissn/1476-5551 |
| DOI: | 10.1038/leu.2017.211 |
| Availability: | https://pure.eur.nl/en/publications/b504f7ec-e6e1-4c07-9640-afad2af3ee24; https://doi.org/10.1038/leu.2017.211; https://hdl.handle.net/1765/104859 |
| Rights: | info:eu-repo/semantics/closedAccess |
| Accession Number: | edsbas.C43BD480 |
| Database: | BASE |